Key takeaways
- Selank is a synthetic analog of tuftsin with anxiolytic properties.
- It modulates GABA signaling, enkephalin breakdown, and serotonin/BDNF expression.
- Selank has shown anxiety benefits comparable to mild anxiolytics in small clinical trials.
- Its effects on mood disorders and depression are not well-studied in Western clinical trials.
Recent studies have explored various treatments for mood disorders and depression, but few have focused on the potential benefits of peptides like Selank. As a calming nootropic peptide, Selank has shown promise in reducing anxiety and improving mood. Its mechanism of action, which involves modulating GABA signaling, enkephalin breakdown, and serotonin/BDNF expression, suggests that it may have a positive impact on mood disorders.
Selank's anxiolytic properties
Selank's anxiolytic properties have been demonstrated in small clinical trials, where it has shown benefits comparable to mild anxiolytics. While these findings are promising, it is essential to note that the evidence is limited, and more research is needed to fully understand Selank's effects on mood disorders and depression. The 3 evidence rating on our scale indicates that while there is some evidence to support Selank's anxiolytic properties, more research is needed to confirm its effectiveness.
Comparison to other treatments
Unfortunately, the provided sources do not offer a comprehensive comparison of Selank to other treatments for mood disorders and depression. However, it is clear that Selank's unique mechanism of action and potential benefits make it an interesting area of study.
The bottom line
While Selank may have potential benefits for mood disorders and depression, its effects are not well-studied in Western clinical trials. As with any research peptide, it is crucial to approach Selank with caution and recognize the limitations of the current evidence.
This is educational information, not medical advice.
Sources
- [Pathophysiological aspects of primary Sjögren's disease : From epithelial activation to systemic autoimmunity] — Zeitschrift fur Rheumatologie, 2026/09/01
- Trends and research clusters in artificial intelligence-assisted ultrasound-guided regional anesthesia: A bibliometric analysis — Digital health, 2026/08/25
- Neural Mechanisms and Efficacy of Imagery Rescripting for Fear of Failure — COMPLETED, NA, 2025-10-02
- Effects of PSAPs on Speech Processing — COMPLETED, NA, 2024-12-05
- The Study on Effects of Acute Exposure to High Altitude Hypoxia on Cognitive Function in Lowlanders — COMPLETED, 2024-10-15
- The Effect of Balance Exercises on Cognitive Function — COMPLETED, NA, 2024-06-27
- Comparing the Efficacy of tDCS and tRNS to Improve Reading Skills in Children and Adolescents With Dyslexia — UNKNOWN, NA, 2023-09-15